180 Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-404
Closed -$209K 379
2022
Q1
$209K Buy
+404
New +$185K 0.05% 344
2019
Q1
Sell
-803
Closed -$220K 262
2018
Q4
$220K Hold
803
0.1% 228
2018
Q3
$220K Sell
803
-61
-7% -$15.8K 0.1% 228
2018
Q2
$206K Sell
864
-294
-25% -$68.1K 0.1% 225
2018
Q1
$258K Buy
+1,158
New +$272K 0.13% 188

Other funds holding ELV

180 Wealth Advisors's ELV Position: Q2 2022 in Review

180 Wealth Advisors sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 404 shares — an estimated $209K sold.

180 Wealth Advisors first reported a position in ELV in Q1 2018 and held it in 5 quarters. The position peaked at $258K in Q1 2018. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • 180 Wealth Advisors reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • 180 Wealth Advisors sold 404 Elevance Health shares in Q2 2022, an estimated $209K.
  • 180 Wealth Advisors first reported a position in Elevance Health in Q1 2018 and held it in 5 quarters.
  • 180 Wealth Advisors's Elevance Health position peaked at $258K in Q1 2018.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on 180 Wealth Advisors's 13F filing for Q2 2022, filed 11 Jul 2022.